(Q52282909)

28 April 2018

title

Design for an ipriflavone multicenter European fracture study. (English)

1 reference

28 April 2018

author name string

Reginster JY

1

1 reference

28 April 2018

Bufalino L

2

1 reference

28 April 2018

Christiansen C

3

1 reference

28 April 2018

Devogelaer JP

4

1 reference

28 April 2018

Gennari C

5

1 reference

28 April 2018

Riis BJ

6

1 reference

28 April 2018

Roux C

7

1 reference

28 April 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

28 April 2018

Calcified Tissue International

published in

1 reference

28 April 2018

volume

61 Suppl 1

1 reference

28 April 2018

page(s)

S28-32

1 reference

28 April 2018

https://scigraph.springernature.com/pub.10.1007/s002239900382

exact match

0 references

cites work

Axial and appendicular bone density predict fractures in older women

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Treatment of postmenopausal osteoporosis with transdermal estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Ipriflavone inhibits murine osteoclast formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

The effect of ipriflavone (TC-80) on bone resorption in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Vertebral fracture assessment using a semiquantitative technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

A comparison of morphometric definitions of vertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Long-term fracture prediction by bone mineral assessed at different skeletal sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Long-term estrogen replacement therapy prevents bone loss and fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Stimulatory effect of ipriflavone on formation of bone-like tissue in rat bone marrow stromal cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Ipriflavone improves bone density and biomechanical properties of adult male rat bones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Ipriflavone does not alter bone apatite crystal structure in adult male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Ipriflavone-treatment of senile osteoporosis: results of a multicenter, double-blind clinical trial of 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900382

21 January 2018

Identifiers

DOI

10.1007/S002239900382

1 reference

28 April 2018

1 reference

28 April 2018